Comparison

Potassium oxonate European Partner

Item no. HY-17511-5g
Manufacturer MedChem Express
CASRN 2207-75-2
Amount 5 g
Quantity options 10mM/1mL 500 mg 5 g
Category
Type Inhibitors
Clone N/A
Specific against other
Purity 99.85
Formula C4H2KN3O4
Citations [1]Shirasaka T, et al. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats. Cancer Res. 1993 Sep 1;53(17):4004-9.<br>[2]Eraranta A, et al. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency. J Hypertens. 2008 Aug;26(8):1661-8.<br>[3]Yoshisue K, et al. Tissue distribution and biotransformation of potassium oxonate after oral administration of a novel antitumor agent (drug combination of tegafur, 5-chloro-2,4-dihydroxypyridine, and potassium oxonate) to rats. Drug Metab Dispos. 2000 Oct;28(10):1162-7.<br>[4]Chen Y, et al. Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice. Biomed Pharmacother. 2019 Oct;118:109195.
Smiles O=C(O[K])C1=NC(O)=NC(O)=N1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Potassium azaorotate; Potassium otastat; Oteracil potassium
Available
Product Description
Potassium oxonate is an inhibitor of uricase, inhibits the phosphorylation of 5-FU to 5-fluorouridine-5'-monophosphate catalyzed by pyrimidine phosphoribosyl-transferase in a different manner from allopurinol in cell-free extracts and intact cells in vitro.
IC50 value:
Target:
On p.o. administration of 5-FU (2 mg/kg) and a potent inhibitor of 5-FU degradation to Yoshida sarcoma-bearing rats, oxonic acid (10 mg/kg) was found to inhibit the formation of 5-fluorouridine-5'-monophosphate from 5-FU and its subsequent incorporation into the RNA fractions of small and large intestine but not of tumor and bone marrow tissues [1]. Oxonic acid diet increased plasma uric acid by 80-90 micromol/l, while blood pressure was elevated only in hyperuricemic 5/6 nephrectomy rats (18 mmHg) [2].
StorageTemperature
4°C (Powder, sealed storage, away from moisture)
Shipping
Room Temperature
Manufacturers Applications
Metabolism-protein/nucleotide metabolism
MolecularWeight
195.17
Clinical_Information
No Development Reported
Manufacturers Research Area
Metabolic Disease
Solubility
DMSO : < 1 mg/mL (ultrasonic; warming; heat to 80°C)|H2O : 3.33 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturers Target
Others
Pathway
Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 g
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close